A Scoping Review of Pharmacologic and Nonpharmacologic Interventions to Treat Chronic Ocular Pain
- 1 September 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of Neuro-Ophthalmology
- Vol. 46 (3) , 301-316
Abstract
Background: Chronic ocular pain (COP) is disabling and a common reason for referral to neuro-ophthalmologists. Many patients with COP suffer from amplified or dysfunctional pain processing in the peripheral nervous system (PNS) or central nervous system (CNS), rather than a problem with the eye itself. The extent of and evidence for therapeutic interventions targeting pain in the PNS and CNS among patients suffering from COP are unknown. Evidence Acquisition: We performed a search of Ovid MEDLINE, Embase.com, Scopus.com, and ClinicalTrials.gov. We limited our search to English-language articles published since 2015. We included observational and experimental studies of pharmacologic and nonpharmacologic interventions (e.g., vagal nerve stimulation) used in adults 18 years or older with COP for at least 3 months. Studies were included if the impact on pain intensity, functioning, or quality of life was measured as primary, secondary, or exploratory outcomes. All articles were independently screened by 2 team members for inclusion. Data extraction was performed independently by 2 team members. Any disagreements during the screening and data extraction processes were adjudicated by a third team member and discussed as a group. Results: Our search identified 9,656 studies from 2015 to 2026. Of those, 21 met our inclusion/exclusion criteria. The study designs were mostly retrospective: 5 case reports, 9 observational, and 1 case–control study; 3 prospective studies were nonrandomized, observational studies. Three studies were randomized clinical trials, but one did not have published results. Most of the studies (67%, n = 14) were on pharmacologic interventions including all 3 completed prospective studies. Pharmacologic interventions included gabapentin, cryosim-3 applied to the eyelids, autologous serum tears, botulinum toxin Type A injections, and nerve blocks. The 6 studies including nonpharmacologic interventions used transcutaneous electrical nerve stimulation, trigeminal ganglion stimulation, and pulsed radiofrequency procedures. The 3 randomized controlled clinical trials were of transcutaneous electrical nerve stimulation, topical ocular cooling device, and topical OK-101 ophthalmic solutions at different concentrations. The most common pain measures used across the studies were pain intensity scales (range 0–10), such as the numeric rating scale. Improvements in COP were reported for most studies. The reporting of adverse events occurred in 8 studies (43%). Conclusions: Although COP is a common symptom, we found few studies on pharmacologic and nonpharmacologic treatment interventions with a few randomized controlled trials. Rigorous studies of treatment interventions aimed at reducing COP are needed. We provide recommendations for both the conduct of future studies and the current approach to COP treatment.Keywords
Funding Information
- National Eye Institute (R01EY036357)
- Research to Prevent Blindness
This publication has 37 references indexed in Scilit:
- A Randomized Double-Masked Study Evaluating Safety and Efficacy of a Novel Topical Cooling Device for Chronic Ocular Surface PainOphthalmology and Therapy, 2026
- Randomized Pilot Study of Transcutaneous Electrical Nerve Stimulation for Neuropathic/Nociplastic Ocular PainAmerican Journal of Ophthalmology, 2026
- Health Care Use for Eye PainJAMA Ophthalmology, 2024
- Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back PainJAMA Psychiatry, 2021
- Gabapentin for presumed neuropathic ocular painAmerican Journal of Ophthalmology Case Reports, 2020
- Efficacy of autologous serum tears for treatment of neuropathic corneal painThe Ocular Surface, 2019
- Resolution of pain with periocular injections in a patient with a 7-year history of chronic ocular painAmerican Journal of Ophthalmology Case Reports, 2019
- Is gabapentin effective in dry eye disease and neuropathic ocular pain?Acta Neurologica Belgica, 2019
- Autologous Serum Tears for Treatment of Photoallodynia in Patients with Corneal Neuropathy: Efficacy and Evaluation with In Vivo Confocal MicroscopyThe Ocular Surface, 2015
- Brain mechanisms of pain relief by transcutaneous electrical nerve stimulation: A functional magnetic resonance imaging studyEuropean journal of pain, 2015